title: Effect of equivalent on-treatment apolipoprotein levels on outcomes (from the AIM-HIGH and HPS2-THRIVE).
authors.affiliation: Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland.
authors.forename: Mohammed
authors.initials: M
authors.lastname: Al-Hijji
authors.forename: Seth S
authors.initials: SS
authors.lastname: Martin
authors.forename: Parag H
authors.initials: PH
authors.lastname: Joshi
authors.forename: Steven R
authors.initials: SR
authors.lastname: Jones
mesh_terms: D001053:Apolipoproteins / Q000097:blood*; D050197:Atherosclerosis / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D001053:Apolipoproteins; D000960:Hypolipidemic Agents